SHCR vs. PIII, MYPS, DCGO, LTCH, TALK, WGS, INNV, PNTG, EDAP, and DSGN
Should you be buying Sharecare stock or one of its competitors? The main competitors of Sharecare include P3 Health Partners (PIII), PLAYSTUDIOS (MYPS), DocGo (DCGO), Latch (LTCH), Talkspace (TALK), GeneDx (WGS), InnovAge (INNV), The Pennant Group (PNTG), Edap Tms (EDAP), and Design Therapeutics (DSGN).
Sharecare (NASDAQ:SHCR) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, community ranking, earnings, valuation and media sentiment.
35.1% of Sharecare shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 29.3% of Sharecare shares are held by insiders. Comparatively, 17.1% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Sharecare received 2 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 35.29% of users gave Sharecare an outperform vote while only 28.57% of users gave P3 Health Partners an outperform vote.
P3 Health Partners has higher revenue and earnings than Sharecare. Sharecare is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
In the previous week, Sharecare had 8 more articles in the media than P3 Health Partners. MarketBeat recorded 12 mentions for Sharecare and 4 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.14 beat Sharecare's score of -0.05 indicating that P3 Health Partners is being referred to more favorably in the news media.
Sharecare has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
P3 Health Partners has a net margin of -4.56% compared to Sharecare's net margin of -28.86%. Sharecare's return on equity of -17.11% beat P3 Health Partners' return on equity.
Sharecare presently has a consensus price target of $1.00, suggesting a potential upside of 45.96%. P3 Health Partners has a consensus price target of $4.75, suggesting a potential upside of 508.97%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Sharecare.
Summary
P3 Health Partners beats Sharecare on 10 of the 18 factors compared between the two stocks.
Get Sharecare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SHCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sharecare Competitors List
Related Companies and Tools
